Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00001589 |
Recruitment Status :
Completed
First Posted : November 4, 1999
Last Update Posted : March 4, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Carotid Atherosclerosis Myocardial Infarction |
Study Type : | Observational |
Enrollment : | 120 participants |
Official Title: | Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors |
Study Start Date : | April 1997 |
Study Completion Date : | May 2002 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
INCLUSION CRITERIA:
Age greater than or equal to 40 years for males and greater than or equal to 50 years for females.
Standard eligibility criteria for blood donation, per guidelines established by the Food and Drug Administration and the American Association of Blood Banks.
Ability to provide consent after full information is provided.
EXCLUSION CRITERIA:
Pregnancy or lactation.
Patients with clinically significant dementia or psychiatric disturbances, including alcohol and substance abuse.
Presence of the following American Heart Association cardiovascular risks: diabetes mellitus, hypertension (systolic greater than 140 mmHg, diastolic greater than 90 mmHg), smoking (greater than 10 cigarettes/day), high density lipoprotein cholesterol less than 35 mg/dL, hyperlipidemia (total cholesterol greater than 240 mg/dL), family history of premature coronary heart disease.
Anticoagulant, thrombolytic, hemorrheologic and/or antiplatelet agents (within the last 10 days).
Any other condition or therapy which in the opinion of the investigators may pose a risk to the patient or confound the results of the study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001589
United States, Maryland | |
Warren G. Magnuson Clinical Center (CC) | |
Bethesda, Maryland, United States, 20892 |
ClinicalTrials.gov Identifier: | NCT00001589 |
Other Study ID Numbers: |
970113 97-CC-0113 |
First Posted: | November 4, 1999 Key Record Dates |
Last Update Posted: | March 4, 2008 |
Last Verified: | May 2002 |
Ferritin Atherosclerosis Myocardial Infarction |
Blood Donors Low Density Lipoprotein Asymptomatic Carotid Atherosclerosis |
Carotid Artery Diseases Myocardial Infarction Atherosclerosis Infarction Ischemia Pathologic Processes Necrosis Myocardial Ischemia Heart Diseases |
Cardiovascular Diseases Vascular Diseases Arteriosclerosis Arterial Occlusive Diseases Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases |